Global Hunter Securities lowered their price target on Savient Pharmaceuticals (Nasdaq: SVNT) from $23 to $15 on news the company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE